- https://gitea.tecamino.com/monserrateruck
-
In 1965, the FDA pressured CIBA to further document its legitimate medical uses, and re-approved the drug for treating post-menopausal osteoporosis and pituitary-deficient dwarfism.
- Joined on
2026-03-29
Block a user
Updated 2026-03-29 22:51:12 +08:00